Editorial Comment on Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study
- PMID: 36924311
- PMCID: PMC11524086
- DOI: 10.1111/iju.15177
Editorial Comment on Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study
Conflict of interest statement
None declared.
Comment on
-
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.Int J Urol. 2023 May;30(5):473-481. doi: 10.1111/iju.15162. Epub 2023 Feb 14. Int J Urol. 2023. PMID: 36788781
References
-
- Matsumoto H, Shiraishi K, Matsuyama H, Inoue K, Uemura H, Eto M, et al. Clinical practice guidelines for bladder cancer 2019 edition by the Japanese Urological Association: revision working position paper. Int J Urol. 2020;27:362–8. - PubMed
-
- Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, et al. Clinical practice guidelines for bladder cancer 2019 update by the Japanese Urological Association: summary of the revision. Int J Urol. 2020;27:702–9. - PubMed
-
- Miyamoto T, Miyake M, Nakahama T, Nishimura N, Onishi K, Iida K, et al. Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non‐muscle invasive bladder cancer: a multi‐institutional collaborative study. Int J Urol. 2023. 10.1111/iju.15162 - DOI - PubMed
-
- Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou‐Redorta J, et al. EAU guidelines on non‐muscle‐invasive urothelial carcinoma of the bladder. Eur Urol. 2008;54:303–14. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
